Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FORGOTTEN HISTORY: 3 - Caught on Camera

Shield Therapeutics revenues boosted by US sales of iron deficiency pills

The pharmaceuticals firm recently joined forced with Pennsylvania-based Viatris to tackle the American market

Birmingham Post

inDrive to roll out Thai service by June

International ride-hailing service operator inDrive is set to launch its service in Thailand by June to capitalise on this fast-growing segment in the country.

Bangkok Post

North East deals of the week: key investments, contracts and acquisitions

Companies involved in deals this week include Mobile Mini, Cascade Cash Management and Ben Johnson Ltd

Birmingham Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Shield Therapeutics secures £15.1m in raise and seals deal with healthcare company

The iron deficiency drug specialist will use the proceeds to mount a campaign on the US market

Birmingham Post

Gray 'unlucky to miss out' on NSW squad for Shield

"Toby Gray is unlucky to miss out after a strong debut last week, but he is a young guy who will look to get more chances as his career develops."

Newcastle Herald

NSW rookie 'hungry for more' and thankful for Lyon's support

Toby Gray, a Valentine junior and Belmont senior, was called up to the Sheffield Shield squad last weekend and given the starting nod on game eve.

Newcastle Herald

Gateshead's Shield Therapeutics says US expansion will be aided by new shelf life ruling

The company launched its lead drug Accrufer in the US last year

Birmingham Post

Read news from The Economist, FT, and more,
with one subscription

Tassie opener Ward hits Shield half-ton

Tasmanian opener Tim Ward has hit a Sheffield Shield half-century against South Australia in Adelaide.

AAP

Losses widen at Shield Therapeutics though sales and prescriptions of its drugs grow

The maker of iron deficiency tablets says there is a huge unmet need for its products in the US were about 20 million people suffer anaemia

Birmingham Post

Some Illinois school districts to ditch COVID-19 tests this fall: ‘The demand really wasn’t there’

CHICAGO — Despite the urging of the state’s health department to resume school-based COVID-19 testing for students this fall, officials at several Illinois districts said this week they are halting the program due to waning interest from parents and the availability of home tests.

Chicago Tribune

Shield Therapeutics finalises $10m loan agreement from cornerstone shareholder

'Shield is fortunate to be able to count on continued support by an established pharmaceutical company like AOP'

Birmingham Post

Marvel leak claims a beloved 'Agents of SHIELD' character will return

It may have seemed like Marvel was scrubbing 'SHIELD' from MCU canon, but a new report claims at least one character will make a comeback.

Inverse

Gateshead's Shield Therapeutics awaits Canadian regulatory approval for iron deficiency drug

The pharmaceutical firm says Health Canada will screen its Accrufer lead product, with an outcome expected next year

Birmingham Post

Pharma firm Shield Therapeutics seals $10m shareholder loan after strong start to 2022

The Gateshead firm also saw a 'transformational' 2021 with licensing activities in the US driving up prescriptions

Birmingham Post

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse

Marvel finally explains 'Avengers: Endgame's biggest unsolved mystery

It's been three years since 'Avengers: Endgame' and we still have one major question. Thankfully, 'Ms. Marvel' provided the answer.

AAP

Shaun Marsh to kick on at WA at age 38

Veteran batsman Shaun Marsh is one step closer to playing as a 40-year-old after signing a one-year contract extension with Western Australia.

Benzinga

L3Harris Partners With Shield Capital To Aid Emerging Defense, Commercial Technologies

L3Harris Technologies Inc (NYSE:LHX) and venture capital firm Shield Capital have established a strategic partnership to accelerate defense, commercial technology solutions. In partnership with Shield, L3Harris will quickly identify, fund, and then guide technology development and solutions that will solve urgent national security needs. The agreement provides L3Harris access to disruptive innovators for…

Fortune

Can A.I. disrupt Big Defense?

Shield AI builds small reconnaissance drones for the U.S. military. Its ambitions are much greater.

Get all your
news in one place.

100's of premium titles.
One news app.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Chicago Public Schools

L3Harris Technologies Inc

25 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.